LP’s allocation to PE is 5.8%, but it wants to commit about 10% of its assets to the sector
1 min read · 01 May 2010
Veteran VC talks about his new job as managing director of corporate development and M&A for National Semiconductor
2 min read · 01 May 2010
Announced Deals is a compilation of venture capital transactions involving European targets announced between March 16 and April 15, 2010.
1 min read · 01 May 2010
Seeking Buyers includes listings of all European companies that have announced plans between March 16 and April 15, 2010, to sell divisions, stakes or their entire company. The listings are ordered by target nation and alphabetically within each country. The data source is Thomson Reuters.
1 min read · 01 May 2010
Skandia Life wants to grow its allocation to PE to 10% in three years from just 3.7% today, and Roger Johanson is the man to see about getting a VC commitment
8 min read · 01 May 2010
Kleiner has doubled the iFund to $200M, with a keen interest in backing developers for the iPad, which Partner John Doerr predicts will “rule the world”
4 min read · 01 May 2010
7 min read · 01 May 2010
The Post-Venture Capital Index rose 6% to 705.72 in March, in its second consecutive monthly gain
1 min read · 01 May 2010
2 min read · 29 April 2010
Mersana Therapeutics Inc. has signed an exclusive research and licensing agreement with Teva Pharmaceutical Industries Ltd., to develop and commercialize a novel fumagillin analog for the treatment of all indications, including cancer. The deal could be worth upwards of $334 million. Cambridge, Mass.-based Mersana Therapeutics has raised around $36 million in VC funding from Fidelity Biosciences, Harris & Harris Group, PureTech Ventures, ProQuest Investments and Rho Ventures.
3 min read · 13 April 2010
